EP4-IN-1

CAS No. 2455480-28-9

EP4-IN-1( —— )

Catalog No. M37063 CAS No. 2455480-28-9

EP4-IN-1 is a potent prostaglandin EP4 receptor inhibitor with potential anti-tumor, anti-inflammatory, and analgesic activities for studying immune and tumor diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 53 Get Quote
10MG 88 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EP4-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    EP4-IN-1 is a potent prostaglandin EP4 receptor inhibitor with potential anti-tumor, anti-inflammatory, and analgesic activities for studying immune and tumor diseases.
  • Description
    EP4-IN-1 is a potent prostanoid EP4 receptor inhibitor. EP4-IN-1 is extracted from patent WO2023025270 (example 1), and exhibits prospectin tumor immunity and anti-inflammatory analgesia research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2455480-28-9
  • Formula Weight
    440.49
  • Molecular Formula
    C27H24N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (567.55 mM; Ultrasonic )
  • SMILES
    N(C(=O)C1=C2N(CC3=CC=4C(O3)=CC=CC4)C=CC2=CC=C1)C5(C67CC(C(O)=O)(C6)C7)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Deng qi yuan,et al.Solid form of indole compound, preparation method therefor and use thereof. Patent WO2023025270A1.
molnova catalog
related products
  • BGC201531

    BGC201531 is a EP4 antagonist for the treatment of acute migraine.

  • Travoprost

    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.

  • ONO-AE3-208

    ONO-AE3-208 is an EP4 antagonist. It suppresses cell migration, invasion, and metastasis of prostate cancer.